These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27632144)

  • 1. Plasma IP-10 Is Increased in Immunological NonResponders and Associated With Activated Regulatory T Cells and Persisting Low CD4 Counts.
    Stiksrud B; Lorvik KB; Kvale D; Mollnes TE; Ueland PM; Trøseid M; Taskén K; Dyrhol-Riise AM
    J Acquir Immune Defic Syndr; 2016 Oct; 73(2):138-48. PubMed ID: 27632144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery.
    Stiksrud B; Aass HCD; Lorvik KB; Ueland T; Trøseid M; Dyrhol-Riise AM
    AIDS; 2019 Jun; 33(7):1117-1129. PubMed ID: 30789356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells in HIV-infected immunological nonresponders are increased in blood but depleted in lymphoid tissue and predict immunological reconstitution.
    Gaardbo JC; Hartling HJ; Ronit A; Springborg K; Gjerdrum LM; Ralfkiær E; Thorsteinsson K; Ullum H; Andersen ÅB; Nielsen SD
    J Acquir Immune Defic Syndr; 2014 Aug; 66(4):349-57. PubMed ID: 24784764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection.
    Prebensen C; Ueland T; Michelsen AE; Lind A; Pettersen FO; Mollnes TE; Aukrust P; Dyrhol-Riise AM; Kvale D
    J Acquir Immune Defic Syndr; 2015 Aug; 69(4):395-402. PubMed ID: 26115437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Tryptophan Catabolism Is Associated With Increased Frequency of CD161+Tc17/MAIT Cells and Lower CD4+ T-Cell Count in HIV-1 Infected Patients on cART After 2 Years of Follow-Up.
    Gaardbo JC; Trøsied M; Stiksrud B; Midttun Ø; Ueland PM; Ullum H; Nielsen SD
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):228-35. PubMed ID: 26470032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells.
    Horta A; Nobrega C; Amorim-Machado P; Coutinho-Teixeira V; Barreira-Silva P; Boavida S; Costa P; Sarmento-Castro R; Castro AG; Correia-Neves M
    PLoS One; 2013; 8(2):e57336. PubMed ID: 23437372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection.
    Liovat AS; Rey-Cuillé MA; Lécuroux C; Jacquelin B; Girault I; Petitjean G; Zitoun Y; Venet A; Barré-Sinoussi F; Lebon P; Meyer L; Sinet M; Müller-Trutwin M
    PLoS One; 2012; 7(10):e46143. PubMed ID: 23056251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
    Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA
    AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of HIV reservoir decay and naïve CD4 T-cell recovery between immune non-responders and complete responders on long-term antiretroviral treatment.
    Zhang LX; Song JW; Zhang C; Fan X; Huang HH; Xu RN; Liu JY; Zhang JY; Wang LF; Zhou CB; Jin L; Shi M; Wang FS; Jiao YM
    Clin Immunol; 2021 Aug; 229():108773. PubMed ID: 34102315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
    Marchetti G; Gori A; Casabianca A; Magnani M; Franzetti F; Clerici M; Perno CF; Monforte Ad; Galli M; Meroni L
    AIDS; 2006 Aug; 20(13):1727-36. PubMed ID: 16931937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of rare HIV-1-infected patients with extreme CD4+ T cell decline despite ART-mediated viral suppression.
    Lisco A; Wong CS; Lage SL; Levy I; Brophy J; Lennox J; Manion M; Anderson MV; Mejia Y; Grivas C; Mystakelis H; Burbelo PD; Perez-Diez A; Rupert A; Martens CA; Anzick SL; Morse C; Chan S; Deleage C; Sereti I
    JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
    Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV immunological non-responders are characterized by extensive immunosenescence and impaired lymphocyte cytokine production capacity.
    Vos WAJW; Navas A; Meeder EMG; Blaauw MJT; Groenendijk AL; van Eekeren LE; Otten T; Vadaq N; Matzaraki V; van Cranenbroek B; Brinkman K; van Lunzen J; Joosten LAB; Netea MG; Blok WL; van der Ven AJAM; Koenen HJPM; Stalenhoef JE
    Front Immunol; 2024; 15():1350065. PubMed ID: 38779686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy.
    Kaufmann GR; Bloch M; Finlayson R; Zaunders J; Smith D; Cooper DA
    AIDS; 2002 Feb; 16(3):359-67. PubMed ID: 11834947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.
    Saison J; Ferry T; Demaret J; Maucort Boulch D; Venet F; Perpoint T; Ader F; Icard V; Chidiac C; Monneret G;
    Clin Exp Immunol; 2014 Jun; 176(3):401-9. PubMed ID: 24460818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study.
    Bordoni V; Brando B; Piselli P; Forini O; Perna FE; Atripaldi U; Carputo S; Garziano F; Trento E; D'Agosto G; Latini A; Colafigli M; Cristaudo A; Sacchi A; Andreoni M; De Carli G; Orchi N; Grelli S; Gatti A; Cerva C; Minutolo A; Potestà M; Di Martino ML; Ortu F; Selva P; Del Pup L; Guarnori I; Lorenzini P; Capuano G; Antinori A; Agrati C
    PLoS One; 2019; 14(12):e0225415. PubMed ID: 31869342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy.
    Hattab S; Guiguet M; Carcelain G; Fourati S; Guihot A; Autran B; Caby F; Marcelin AG; Costagliola D; Katlama C
    HIV Med; 2015 Oct; 16(9):553-62. PubMed ID: 25944318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up.
    Carsenti-Dellamonica H; Saïdi H; Ticchioni M; Guillouet de Salvador F; Dufayard Cottalorda J; Garraffo R; Dellamonica P; Durant J; Gougeon ML
    HIV Med; 2011 Feb; 12(2):65-77. PubMed ID: 20500532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of IL-6, MIP-1β, IP-10, and PTX-3 as predictors of the immunological response to antiretroviral treatment in people with HIV.
    Mejías-Trueba M; Saborido-Alconchel A; Serna-Gallego A; Trujillo-Rodríguez M; Muñoz-Muela E; Llaves-Flores S; Espinosa N; Roca-Oporto C; Herrero M; Sotomayor C; López-Cortes LF
    Front Immunol; 2024; 15():1447926. PubMed ID: 39267754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incomplete functional T-cell reconstitution in immunological non-responders at one year after initiation of antiretroviral therapy possibly predisposes them to infectious diseases.
    Shete A; Dhayarkar S; Sangale S; Medhe U; Panchal N; Rahane G; Yelgate R; Dhamanage A; Gangakhedkar R
    Int J Infect Dis; 2019 Apr; 81():114-122. PubMed ID: 30658168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.